NIH Low Dose Aspirin and Pregnancy Study

From: Faculty and Research E-Memo (memofrom@Colorado.EDU)
Date: Sun Nov 15 2009 - 15:17:10 MST

  • Next message: Faculty and Research E-Memo: "Hazel Barnes Prize Pre-call for Nominations"
    Date: Sun, 15 Nov 2009 15:17:10 -0700 (MST)
    From: Faculty and Research E-Memo <memofrom@Colorado.EDU>
    Subject:  NIH Low Dose Aspirin and Pregnancy Study
    

    TO: Boulder Campus Teaching & Research Faculty,
              Deans, Directors, Dept Chairs, System Administration

    FROM: Obstetrics and Gynecology
              University of Colorado School of Medicine

    SENDER: Anne Lynch MD MSPH - Principal Investigator

    DATE: November 16, 2009

    SUBJECT: NIH Low Dose Aspirin and Pregnancy Study

    An important NIH Study of Low Dose Aspirin and its effect on gestation and
    reproduction is being conducted at four clinical sites across the US
    including in the Dept of Ob/Gyn at University of Colorado School of
    Medicine.

    Principal Investigator is Dr. Anne Lynch - Perinatal Epidemiologist in the
    Dept of Ob/Gyn CU SOM who leads the "EAGeR" Study (Effects of Aspirin on
    Gestation and Reproduction) to evaluate low dose aspirin compared to placebo
    in women who have had one or two pregnancy losses in the past are interested
    in becoming pregnant. In a recent interview, Dr. Lynch said, "The hypothesis
    is that because aspirin reduces the ability to form blood clots, it can
    improve utero-placental blood flow and increase the chances of conception.
    Because of the improvement in blood flow, we think this will improve
    implantation. We feel that aspirin's anti-inflammatory effects will improve
    success for pregnancy." The EAGeR will include 1,600 women nationally.

    Please help support the EAGeR Study Recruiting Effort - Share this
    information.

    We are seeking women 18-40 who have had one or two pregnancy losses and are
    considering becoming pregnant again. Participants will go to their own
    doctors and may deliver their babies wherever they choose. Participants
    receive a highly sensitive fertility monitor, pregnancy tests, free folic
    acid supplement along with the study medications, a 6.5 week ultrasound when
    they become pregnancy, support from a caring research team and compensation
    for participation.

    EAGeR phone number 303-724-3525
    Anne.lynch@ucdenver.edu


  • Next message: Faculty and Research E-Memo: "Hazel Barnes Prize Pre-call for Nominations"

    This archive was generated by hypermail 2.1.6 : Sun Nov 15 2009 - 15:17:11 MST